Literature DB >> 17702824

Stimulatory and costimulatory effects of IL-18 directed to different small intestinal CD43 T cell subsets.

Dina Montufar-Solis1, Heuy-Ching Wang, John R Klein.   

Abstract

This study has examined the stimulatory and costimulatory effects of IL-18 on two subsets of murine small intestinal intraepithelial lymphocytes (IELs) defined by the expression of the CD43 S7 glycoform. Data from gene array studies and real-time PCR indicated that S7(+) IELs had significantly higher levels of gene expression for the IL-18 receptor and the IL-18R accessory protein than S7(-) IELs. IL-18 costimulation of IELs in conjunction with CD3-induced activation resulted in significantly greater proliferation than CD3 stimulation alone. In CFSE dilution experiments, IL-18 costimulation favored the S7(+) IEL population. IL-18 costimulation did not affect apoptosis of either S7(-) or S7(+) IELs compared with CD3 stimulation alone. Although IL-18 costimulation did not alter the total number of IFN-gamma-producing cells relative to CD3 stimulation alone, twice as many S7(+) IELs were IFN-gamma -secreting cells than S7(-) IELs in both CD3-stimulated and IL-18-costimulated cultures. Notably, direct IL-18 stimulation in the absence of CD3 activation induced an IFN-gamma response that was predominantly directed to the S7(+) population, indicating that IL-18 is itself an IFN-gamma activational signal for intestinal T cells. In contrast, direct IL-18 stimulation of IELs did not generate TNF-alpha-producing cells, indicating a differential response in the activation of proinflammatory cytokines following IL-18 exposure. These findings point to distinctly different activational effects of IL-18 on IELs, both with regard to the type of functional responses elicited and with respect to the IEL subsets affected.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17702824      PMCID: PMC2582815          DOI: 10.1189/jlb.0207108

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  54 in total

Review 1.  Therapeutic approaches in inflammatory bowel disease based on the immunopathogenesis.

Authors:  B Siegmund; M Zeitz
Journal:  Rocz Akad Med Bialymst       Date:  2004

2.  IL-18 bridges innate and adaptive immunity through IFN-gamma and the CD134 pathway.

Authors:  Joseph R Maxwell; Rajwardhan Yadav; Robert J Rossi; Carl E Ruby; Andrew D Weinberg; Hector L Aguila; Anthony T Vella
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

3.  Selective death of T cell receptor gamma/delta+ intraepithelial lymphocytes by apoptosis.

Authors:  J L Viney; T T MacDonald
Journal:  Eur J Immunol       Date:  1990-12       Impact factor: 5.532

4.  Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production.

Authors:  B Siegmund; G Fantuzzi; F Rieder; F Gamboni-Robertson; H A Lehr; G Hartmann; C A Dinarello; S Endres; A Eigler
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-10       Impact factor: 3.619

5.  Upregulation of ICOS on CD43+ CD4+ murine small intestinal intraepithelial lymphocytes during acute reovirus infection.

Authors:  Dina Montufar-Solis; Tomas Garza; Ba-Bie Teng; John R Klein
Journal:  Biochem Biophys Res Commun       Date:  2006-02-17       Impact factor: 3.575

6.  Elevated systemic levels of free interleukin-18 (IL-18) in patients with Crohn's disease.

Authors:  Othmar Ludwiczek; Arthur Kaser; Daniela Novick; Charles A Dinarello; Menachem Rubinstein; Herbert Tilg
Journal:  Eur Cytokine Netw       Date:  2005 Jan-Mar       Impact factor: 2.737

7.  Prior elevation of IL-18 promotes rapid early IFN-gamma production during staphylococcal infection.

Authors:  Shauna Culshaw; Bernard P Leung; J Alastair Gracie; Carol C Campbell; Duncan Thomson; Curtis Gemmell; Foo Y Liew; Iain B McInnes
Journal:  Eur J Immunol       Date:  2005-05       Impact factor: 5.532

8.  Diverse populations of T cells with NK cell receptors accumulate in the human intestine in health and in colorectal cancer.

Authors:  Joan O'Keeffe; Derek G Doherty; Tony Kenna; Kieran Sheahan; Diarmuid P O'Donoghue; John M Hyland; Cliona O'Farrelly
Journal:  Eur J Immunol       Date:  2004-08       Impact factor: 5.532

9.  Intestinal intraepithelial lymphocytes are activated and cytolytic but do not proliferate as well as other T cells in response to mitogenic signals.

Authors:  B C Sydora; P F Mixter; H R Holcombe; P Eghtesady; K Williams; M C Amaral; A Nel; M Kronenberg
Journal:  J Immunol       Date:  1993-03-15       Impact factor: 5.422

10.  Detection and characterization of cytotoxic T lymphocyte precursors in the murine intestinal intraepithelial leukocyte population.

Authors:  P B Ernst; D A Clark; K L Rosenthal; A D Befus; J Bienenstock
Journal:  J Immunol       Date:  1986-03-15       Impact factor: 5.422

View more
  5 in total

1.  A role for IL-10 in the transcriptional regulation of Roquin-1.

Authors:  Jeremy S Schaefer; Dina Montufar-Solis; John R Klein
Journal:  Gene       Date:  2014-07-23       Impact factor: 3.688

2.  Involvement of Ly6C, 4-1BB, and KLRG1 in the activation of lamina propria lymphocytes in the small intestine of sanroque mice.

Authors:  Dina Montufar-Solis; Alexander Williams; Nadarajah Vigneswaran; John R Klein
Journal:  Biochem Biophys Res Commun       Date:  2016-12-21       Impact factor: 3.575

3.  ICOS promotes IL-17 synthesis in colonic intraepithelial lymphocytes in IL-10-/- mice.

Authors:  Jeremy S Schaefer; Dina Montufar-Solis; Nadarajah Vigneswaran; John R Klein
Journal:  J Leukoc Biol       Date:  2009-11-04       Impact factor: 4.962

4.  Augmentation of Antitumor Immunity by Human and Mouse CAR T Cells Secreting IL-18.

Authors:  Biliang Hu; Jiangtao Ren; Yanping Luo; Brian Keith; Regina M Young; John Scholler; Yangbing Zhao; Carl H June
Journal:  Cell Rep       Date:  2017-09-26       Impact factor: 9.423

5.  Small intestine inflammation in Roquin-mutant and Roquin-deficient mice.

Authors:  Jeremy S Schaefer; Dina Montufar-Solis; Niyati Nakra; Nadarajah Vigneswaran; John R Klein
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.